Protein Kinase CK2 Regulates Nerve/Glial Antigen (NG)2-Mediated Angiogenic Activity of Human Pericytes
Open Access
Abstract
Protein kinase CK2 is a crucial regulator of endothelial cell proliferation, migration and sprouting during angiogenesis. However, it is still unknown whether this kinase additionally affects the angiogenic activity of other vessel-associated cells. In this study, we investigated the effect of CK2 inhibition on primary human pericytes. We found that CK2 inhibition reduces the expression of nerve/glial antigen (NG)2, a crucial factor which is involved in angiogenic processes. Reporter gene assays revealed a 114 bp transcriptional active region of the human NG2 promoter, whose activity was decreased after CK2 inhibition. Functional analyses demonstrated that the pharmacological inhibition of CK2 by CX-4945 suppresses pericyte proliferation, migration, spheroid sprouting and the stabilization of endothelial tubes. Moreover, aortic rings of NG2−/− mice showed a significantly reduced vascular sprouting when compared to rings of NG2+/+ mice, indicating that NG2 is an important regulator of the angiogenic activity of pericytes. In vivo, implanted Matrigel plugs containing CX-4945-treated pericytes exhibited a lower microvessel density when compared to controls. These findings demonstrate that CK2 regulates the angiogenic activity of pericytes through NG2 gene expression. Hence, the inhibition of CK2 represents a promising anti-angiogenic strategy, because it does not only target endothelial cells, but also vessel-associated pericytes.Keywords
Funding Information
- HOMFORexzellenz (2016/2017)
This publication has 52 references indexed in Scilit:
- Function of protein kinase CK2 in thrombus formationPlatelets, 2018
- Protein Kinase CK2 and AngiogenesisAdvances in Clinical and Experimental Medicine, 2014
- Kinase CK2 Inhibition: An UpdateCurrent Medicinal Chemistry, 2013
- CK2 and the regulation of the carbohydrate metabolismMetabolism, 2012
- Protein kinase CK2 is a regulator of angiogenesis in endometriotic lesionsAngiogenesis, 2012
- CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor EfficacyCancer Research, 2010
- 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2Biochemical and Biophysical Research Communications, 2004
- One‐thousand‐and‐one substrates of protein kinase CK2?The FASEB Journal, 2003
- Protein kinase CK2: structure, regulation and role in cellular decisions of life and deathBiochemical Journal, 2003
- Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cellsBiochemical Journal, 2002